TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32330415

Group type: EXPERIMENTAL
Intervention: Closed-loop demultiplexing brain-computer interface (BCI)
Number of subjects: 1
Study: 35366528

Group type: EXPERIMENTAL
Intervention: tACS-30 (30 min/2 mA daily sessions for 3 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: tACS-60 (60 min/2 mA weekday sessions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33496330

Group type: EXPERIMENTAL
Intervention: Child Development Agents (CDA)
Number of subjects: 826

Group type: EXPERIMENTAL
Intervention: Community Health Workers (CHW)
Number of subjects: 826

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 826
Study: 32941332

Group type: EXPERIMENTAL
Intervention: Scleral lenses (SLs)
Number of subjects: 26
Study: 34247247

Group type: EXPERIMENTAL
Intervention: Clinical-radiomics nomogram model
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: Rad-score from radiomics features
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: Calibration curves and Decision Curve Analysis (DCA)
Number of subjects: 638
Study: 32461568

Group type: EXPERIMENTAL
Intervention: Arclight ophthalmoscope
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional ophthalmoscope (TO)
Number of subjects: 40
Study: 32141043

Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound-guided liver biopsy (EUS-LB)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Percutaneous liver biopsy (PC-LB)
Number of subjects: 90
Study: 33962026

Group type: EXPERIMENTAL
Intervention: Home-based multimodal exercise program (AD-HOMEX), 16-week protocol, three 60-minute sessions per week supervised by a physical therapist
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Home-based multimodal exercise program (AD-HOMEX)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care (Control Group)
Number of subjects: 40
Study: 33225982

Group type: EXPERIMENTAL
Intervention: Automated, individualized education through a smartphone app (Yi tang yun qiao)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 138
Study: 35338534

Group type: EXPERIMENTAL
Intervention: 1-week massed cognitive processing therapy (CPT) delivered virtually, twice per day for 5 days
Number of subjects: 24
Study: 33385632

Group type: EXPERIMENTAL
Intervention: Brain training games over a 30‐day period
Number of subjects: 352

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 352
Study: 32981029

Group type: EXPERIMENTAL
Intervention: Phenazopyridine
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Oxybutynin
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 35193056

Group type: EXPERIMENTAL
Intervention: Providing vouchers redeemable in local optical shops
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Health education campaign
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Free delivery to schools with a health education campaign
Number of subjects: 251

Group type: COMPARATOR
Intervention: Voucher redemption or prescription for eyeglasses to be purchased on the market
Number of subjects: 251
Study: 33737196

Group type: EXPERIMENTAL
Intervention: Gentle physical activity program delivered by home care aides
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 300
Study: 33507461

Group type: EXPERIMENTAL
Intervention: Bandage contact lens (BCL)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study: 32981874

Group type: EXPERIMENTAL
Intervention: SMARTLock hybrid MMF
Number of subjects: 32

Group type: COMPARATOR
Intervention: IMF screws
Number of subjects: 32
Study: 35067356

Group type: EXPERIMENTAL
Intervention: Active dTMS
Number of subjects: 51

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 51
Study: 33556898

Group type: EXPERIMENTAL
Intervention: Nivolumab plus Ipilimumab (NIVO+IPI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dabrafenib plus Trametinib (DAB+TRAM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vemurafenib plus Cobimetinib (VEM+COBI)
Number of subjects: 0
Study: 35365121

Group type: EXPERIMENTAL
Intervention: cM1 low frequency rTMS (n = 20)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: cPMd high frequency rTMS (n = 20)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham stimulation group (n = 20)
Number of subjects: 60
Study: 33743679

Group type: EXPERIMENTAL
Intervention: Out-of-pocket payments (OOPs) by MS patients
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Occupational status, supplemental health insurance, residency in Tabriz
Number of subjects: 300
Study: 32616227

Group type: EXPERIMENTAL
Intervention: Fractured keel (FK) hens
Number of subjects: 90

Group type: COMPARATOR
Intervention: Normal keel (NK) hens
Number of subjects: 90
Study: 36274566

Group type: EXPERIMENTAL
Intervention: Internet-based single-session intervention targeting parent accommodation
Number of subjects: 295
Study: 34761749

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amisulpride
Number of subjects: 0
Study: 35970918

Group type: EXPERIMENTAL
Intervention: 5.45% sodium chloride solution (group B)
Number of subjects: 657

Group type: EXPERIMENTAL
Intervention: 10% sodium chloride solution (group C)
Number of subjects: 657

Group type: COMPARATOR
Intervention: 0.9% sodium chloride solution (group A)
Number of subjects: 657
Study: 32988366

Group type: EXPERIMENTAL
Intervention: Ultrasound group (n = 40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Landmark group (n = 40)
Number of subjects: 80
Study: 35713110

Group type: EXPERIMENTAL
Intervention: 10-week internet-based cognitive-behavioral therapy (iCBT), n = 26
Number of subjects: 52

Group type: COMPARATOR
Intervention: Monitored attention control (MAC), n = 26
Number of subjects: 52
Study: 34174187

Group type: EXPERIMENTAL
Intervention: Seasonal influenza vaccination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AS03-adjuvanted H5N1 pandemic influenza vaccine
Number of subjects: 0
Study: 33934320

Group type: EXPERIMENTAL
Intervention: CD for arrest of descent (n = 136)
Number of subjects: 525

Group type: EXPERIMENTAL
Intervention: CD for arrest of dilation (n = 389)
Number of subjects: 525

Group type: COMPARATOR
Intervention: Pre-2014 CD
Number of subjects: 525

Group type: COMPARATOR
Intervention: Post-2014 CD
Number of subjects: 525
Study: 33185716

Group type: EXPERIMENTAL
Intervention: Wearable UV sensor with structured goal setting
Number of subjects: 60

Group type: COMPARATOR
Intervention: Wearable UV sensor with unstructured goal setting
Number of subjects: 60
Study: 32444091

Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35385778

Group type: EXPERIMENTAL
Intervention: Blastocyst culture supernatant transfer (Group A)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Embryo culture transfer (Group B)
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Blastocyst culture supernatant transfer (Group A) in patients aged ≥35 years
Number of subjects: 288

Group type: COMPARATOR
Intervention: Embryo culture transfer (Group B) in patients aged ≥35 years
Number of subjects: 288
Study: 33572988

Group type: EXPERIMENTAL
Intervention: Immediately loaded prosthesis (one week)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Early-loaded prosthesis (four weeks)
Number of subjects: 21
Study: 32164507

Group type: EXPERIMENTAL
Intervention: 177Lu-PSMA-radioligand therapy
Number of subjects: 0
Study: 36161146

Group type: EXPERIMENTAL
Intervention: 20 mg escitalopram
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 33939253

Group type: COMPARATOR
Intervention: Organ-based tube current modulation (OBTCM)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Automatic tube current modulation (ATCM)
Number of subjects: 34
Study: 36368169

Group type: EXPERIMENTAL
Intervention: Telerehabilitation (TR) group received real-time motor-cognitive dual-task exercise treatment via video conferencing for 6 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group received no intervention for 6 weeks
Number of subjects: 20
Study: 35134323

Group type: EXPERIMENTAL
Intervention: Guselkumab 200 mg
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Guselkumab 600 mg
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Guselkumab 1200 mg
Number of subjects: 309

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Ustekinumab
Number of subjects: 309
Study: 34919983

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 34168032

Group type: EXPERIMENTAL
Intervention: Anaerobic Cultivated Human Intestinal Microbiome (ACHIM)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: ACHIM
Number of subjects: 70
Study: 32221178

Group type: EXPERIMENTAL
Intervention: Antidepressive medications plus cognitive behavioral therapy
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Antidepressive medications plus dynamic psychotherapy
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Antidepressive medications plus psychotherapy (both types)
Number of subjects: 12
Study: 34190962

Group type: EXPERIMENTAL
Intervention: Zuranolone, 30 mg, administered orally each evening for 2 weeks
Number of subjects: 153

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Zuranolone, 30 mg
Number of subjects: 153
Study: 33251929

Group type: EXPERIMENTAL
Intervention: Toothbrushing to the best of their abilities
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Time brushed by circular movements
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Number of sextants brushed for at least 7.5 s
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Circular movements
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Behavioral aspects related to inner surfaces
Number of subjects: 174
Study: 33588112

Group type: EXPERIMENTAL
Intervention: Lymph Node Collection Kit
Number of subjects: 3734

Group type: EXPERIMENTAL
Intervention: Heightened Awareness (HA)
Number of subjects: 3734

Group type: COMPARATOR
Intervention: Preintervention (Baseline)
Number of subjects: 3734
Study: 32585169

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 34000608

Group type: EXPERIMENTAL
Intervention: Pelvic belt during trunk stability exercises
Number of subjects: 24
Study: 32915796

Group type: EXPERIMENTAL
Intervention: Vibration (Vib) during maximal graded cycling exercise
Number of subjects: 12

Group type: COMPARATOR
Intervention: No Vibration (noVib) during maximal graded cycling exercise
Number of subjects: 12
Study: 36424687

Group type: EXPERIMENTAL
Intervention: Melatonin 5 mg
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo (identical glucose tablets)
Number of subjects: 84
Study: 32789528

Group type: COMPARATOR
Intervention: Montmorency tart cherry juice (MTCJ) supplementation for 7 days
Number of subjects: 12
Study: 34690065

Group type: EXPERIMENTAL
Intervention: Spironolactone 25 mg daily for 3 months
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 36347450

Group type: EXPERIMENTAL
Intervention: Green tea (GT) supplementation (738 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 33872056

Group type: EXPERIMENTAL
Intervention: ACLR+LET
Number of subjects: 18

Group type: COMPARATOR
Intervention: iACLR
Number of subjects: 18
Study: 35646354

Group type: EXPERIMENTAL
Intervention: Dietary counseling
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Physical activity counseling
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Diet and physical activity counseling
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 36107598

Group type: EXPERIMENTAL
Intervention: Superficial serratus plane block
Number of subjects: 60
Study: 33025645

Group type: EXPERIMENTAL
Intervention: 6-mm implants
Number of subjects: 95

Group type: COMPARATOR
Intervention: 11-mm implants
Number of subjects: 95
Study: 32780138

Group type: EXPERIMENTAL
Intervention: Liberal transfusion thresholds (n=492)
Number of subjects: 1013

Group type: COMPARATOR
Intervention: Restrictive transfusion thresholds (n=521)
Number of subjects: 1013
Study: 35094914

Group type: EXPERIMENTAL
Intervention: Hypofractionated whole-breast irradiation (HF-WBI)
Number of subjects: 718

Group type: COMPARATOR
Intervention: Conventionally fractionated whole-breast irradiation (CF-WBI)
Number of subjects: 718
Study: 34538253

Group type: EXPERIMENTAL
Intervention: LGO-S (Let's Get Organized) intervention for 10 weeks
Number of subjects: 104

Group type: COMPARATOR
Intervention: Treatment as usual (individual occupational therapy)
Number of subjects: 104
Study: 32853384

Group type: EXPERIMENTAL
Intervention: Lattice radiation therapy (LRT) with a dose of 24 Gy in three fractions, followed by conventionally fractionated external beam irradiation to 44.28 Gy
Number of subjects: 10
Study: 33338415

Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (1000 mg) administered via intramuscular injection at baseline, 6 weeks, and then every 3 months for 2 years.
Number of subjects: 1007

Group type: COMPARATOR
Intervention: Placebo administered via intramuscular injection at baseline, 6 weeks, and then every 3 months for 2 years.
Number of subjects: 1007

Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (1000 mg) administered via intramuscular injection.
Number of subjects: 1007

Group type: COMPARATOR
Intervention: Placebo administered via intramuscular injection.
Number of subjects: 1007
Study: 32147751

Group type: EXPERIMENTAL
Intervention: MOP1 group received 3 MOPs on the buccal surface of alveolar bone
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: MOP2 group received 3 buccal MOPs and 3 palatal MOPs
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control side (no MOPs)
Number of subjects: 28
Study: 34328029

Group type: EXPERIMENTAL
Intervention: CoYoT1 Clinic (TH+VGA; n=23)
Number of subjects: 53

Group type: COMPARATOR
Intervention: TH-only (n=35)
Number of subjects: 53
Study: 33930663

Group type: EXPERIMENTAL
Intervention: Parent-Child Interaction Therapy (PCIT)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Services as usual (SAU)
Number of subjects: 55
Study: 33196446

Group type: EXPERIMENTAL
Intervention: CT‐QFR
Number of subjects: 231

Group type: COMPARATOR
Intervention: MPS
Number of subjects: 231

Group type: COMPARATOR
Intervention: CMR
Number of subjects: 231
Study: 32134956

Group type: EXPERIMENTAL
Intervention: Naltrexone (NTX) 50 mg daily
Number of subjects: 155

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Naltrexone (NTX)
Number of subjects: 155
Study: 35381069

Group type: EXPERIMENTAL
Intervention: Daily prednisone (0.75 mg/kg)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Daily deflazacort (0.90 mg/kg)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Intermittent prednisone (0.75 mg/kg for 10 days on and then 10 days off)
Number of subjects: 196
Study: 34485814

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 3649

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3649
Study: 32587591

Group type: EXPERIMENTAL
Intervention: PD-1/PD-L1 inhibitors
Number of subjects: 308
Study: 35493119

Group type: EXPERIMENTAL
Intervention: Ibrutinib 420 mg plus standard of care (SOC)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo plus standard of care (SOC)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Ibrutinib plus SOC
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo plus SOC
Number of subjects: 46
Study: 33026598

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 33567080

Group type: EXPERIMENTAL
Intervention: Occipitoatlantal decompression (OAD)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham touch
Number of subjects: 30
Study: 32664602

Group type: EXPERIMENTAL
Intervention: Physical activity levels
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: At-risk groups (female, overweight/obese, non-smoking, poor fitness perceptions, low fruit/vegetable consumption, excess screen-based sedentariness)
Number of subjects: 414

Group type: COMPARATOR
Intervention: UK National Physical Activity Guidelines
Number of subjects: 414
Study: 35219505

Group type: EXPERIMENTAL
Intervention: Pragmatic trials in long-term care
Number of subjects: 0
Study: 33823506

Group type: EXPERIMENTAL
Intervention: Visually guided saccades (VGSs)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Contralateral VGSs relative to the side of the more severely affected striatum
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Dopamine transporter (DAT) SPECT specific binding ratio (SBR)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal controls (NCs)
Number of subjects: 50
Study: 32866619

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (ET; 3 days/week, 45 minutes/day for 8 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Non-exercise control group (CON)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (ET)
Number of subjects: 40
Study: 35544293

Group type: EXPERIMENTAL
Intervention: High social presence group
Number of subjects: 206

Group type: COMPARATOR
Intervention: Low social presence group
Number of subjects: 206
Study: 32728881

Group type: EXPERIMENTAL
Intervention: High-protein meal (En% F/C/P: 10.6, 51.5, 36.9)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High-carbohydrate meal (En% F/C/P: 9.6, 81.5, 8.6)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High-fat meal (En% F/C/P: 52.3, 39.2, 8.0)
Number of subjects: 18

Group type: COMPARATOR
Intervention: All meals
Number of subjects: 18
Study: 35662050

Group type: EXPERIMENTAL
Intervention: iCanQuit
Number of subjects: 348

Group type: COMPARATOR
Intervention: QuitGuide
Number of subjects: 348
Study: 32989597

Group type: EXPERIMENTAL
Intervention: BioRootTM RCS (Septodont) with single-cone technique
Number of subjects: 69

Group type: COMPARATOR
Intervention: Gutta-percha and zinc oxide-eugenol sealer (ZOE) with warm vertical compaction
Number of subjects: 69
Study: 33159336

Group type: EXPERIMENTAL
Intervention: New Forest Parenting Programme (NFPP‐SH) + Treatment as Usual (TAU)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 52
Study: 32929756

Group type: EXPERIMENTAL
Intervention: Copula-based construction of the joint density of the marker and the outcome using Gaussian copula and customized margin for the marker.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Estimation using maximum likelihood and resampling-based methods.
Number of subjects: 0
Study: 34636914

Group type: EXPERIMENTAL
Intervention: 3A-HBV (10 μg)
Number of subjects: 2838
Study: 36380220

Group type: EXPERIMENTAL
Intervention: Cannabis with 0 mg CBD (0:1 CBD:THC)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Cannabis with 10 mg CBD (1:1 CBD:THC)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Cannabis with 20 mg CBD (2:1 CBD:THC)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Cannabis with 30 mg CBD (3:1 CBD:THC)
Number of subjects: 46
Study: 33988760

Group type: EXPERIMENTAL
Intervention: AcroQoL questionnaire
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: EQ‐5D‐5L index score
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: OLS model using AcroQoL scores
Number of subjects: 424
Study: 33356790

Group type: EXPERIMENTAL
Intervention: Practice facilitation intervention
Number of subjects: 6
Study: 34444958

Group type: EXPERIMENTAL
Intervention: Antenatal lifestyle intervention (low-GI diet and physical activity)
Number of subjects: 434

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Antenatal lifestyle intervention
Number of subjects: 434
Study: 32054315

Group type: EXPERIMENTAL
Intervention: Pivotal response treatment package
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (usual intervention services)
Number of subjects: 48
Study: 35130850

Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate (0.1%) combined with rhEGF (20 μg/ml)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Sodium hyaluronate (0.1%)
Number of subjects: 106
Study: 33930388

Group type: EXPERIMENTAL
Intervention: Acute stress task (ScanSTRESS‐C; n = 40)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control condition (n = 41)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Cognitive Emotion Regulation Task (CERT) with distraction and reappraisal
Number of subjects: 81

Group type: COMPARATOR
Intervention: Cognitive Emotion Regulation Task (CERT)
Number of subjects: 81
Study: 34446491

Group type: EXPERIMENTAL
Intervention: Gallstone disease (GD) cohort
Number of subjects: 343300

Group type: EXPERIMENTAL
Intervention: Non-cholecystectomy patients with GD
Number of subjects: 343300

Group type: EXPERIMENTAL
Intervention: Cholecystectomy patients with GD
Number of subjects: 343300

Group type: COMPARATOR
Intervention: Non-GD cohort (control)
Number of subjects: 343300
Study: 32618694

Group type: EXPERIMENTAL
Intervention: Time-weighted-average-mean arterial pressure below 75 mm Hg
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Time-weighted-average-mean arterial pressure below 70 mm Hg
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Time-weighted-average-mean arterial pressure below 65 mm Hg
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Time-weighted-average-mean arterial pressure below 60 mm Hg
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Time-weighted-average-mean arterial pressure below 55 mm Hg
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Cumulative-time-below 75 mm Hg
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Cumulative-time-below 70 mm Hg
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Cumulative-time-below 65 mm Hg
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Cumulative-time-below 60 mm Hg
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Cumulative-time-below 55 mm Hg
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Mean arterial pressure less than 65 mm Hg
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Mean arterial pressure less than 60 mm Hg
Number of subjects: 273